Monthly Archives: June 2007

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and the College On Problems of Drug Dependence (CPDD) will jointly present the 2007 Media Award to John Hoffman, Vice President, Home Box Office (HBO) Documentary, for his role in co-producing the groundbreaking HBO documentary series “Addiction.”
Continue reading →

Few older people die with brains untouched by a pathological process, however, an individual’s likelihood of having clinical signs of dementia increases with the number of different disease processes present in the brain, according to a new study. The research was funded by the National Institute on Aging (NIA), part of the National Institutes of Health, and conducted at the Rush Alzheimer’s Disease Center at Rush University Medical Center in Chicago. Julie Schneider, M.D., and colleagues report the findings in the journal Neurology online today.
Continue reading →

An international research consortium today published a set of papers that promise to reshape our understanding of how the human genome functions. The findings challenge the traditional view of our genetic blueprint as a tidy collection of independent genes, pointing instead to a complex network in which genes, along with regulatory elements and other types of DNA sequences that do not code for proteins, interact in overlapping ways not yet fully understood.
Continue reading →

The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today it will provide $20.65 million for 14 High-End Instrumentation (HEI) grants that will fund cutting-edge equipment required to advance biomedical research. Awarded to research institutions around the country, the one-time grants support the purchase of sophisticated instruments costing more than $750,000.
Continue reading →

A team of researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has uncovered a set of genes that are turned on, or expressed, at high levels only in the blood vessels that feed tumors in mice and humans. These genes, and the proteins they encode, are important new potential targets for novel drugs that could selectively cut off a tumor’s blood supply without affecting the blood vessels of healthy tissues, overcoming one of the major concerns of current anticancer therapies targeted at blood vessel growth.
Continue reading →

New research supported by the National Institutes of Health’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) shows that the anticonvulsant medication gabapentin, which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with the common, often hard-to-treat chronic pain disorder, fibromyalgia.
Continue reading →

Alzheimer’s disease researchers may be able to reduce the time and expense associated with clinical trials, according to early results from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a public-private research partnership organized by the National Institutes of Health. Preliminary results from ADNI show how it might yield improved methods and uniform standards for imaging and biomarker analysis, so these techniques can be employed in the fight against Alzheimer’s disease.
Continue reading →

National Institutes of Health (NIH) Director Elias A. Zerhouni, M.D., announced today the formation of two working groups—one external, the other internal ? to examine the NIH peer review process, with the goal of maximizing its effectiveness.
Continue reading →

Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, have discovered a survival mechanism in a common type of bacteria that can cause illness. The mechanism lets the bacteria protect itself by warding off attacks from antimicrobial peptides (AMPs), which are defense molecules sent by the body to kill bacteria.
Continue reading →

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), today released its NIAID Research Agenda for Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) Tuberculosis (TB).
Continue reading →